Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs
Shipment of GMP DMT, In Vitro HERG and Genotox Assays Completed, and In Vivo Toxicity Assays Underway
Who we are
Entheon is in a unique position to challenge the narrative – and expectations – around addiction recovery.
Leveraging emerging bio-technology, we are pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorder. Focusing primarily on the powerful DMT molecule, Entheon exists to invert the addiction recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception.
Learn More About Entheon
Investors
